Q2 2026 Holdings
Filed 2026-08-14 | 88 holdings | $524.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $105.4M | 562,630 | 20.1% |
| Spdr S&P Biotech ETF(XBI) | ETF | 78464A870 | $31.1M | 196,505 | 5.9% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $28.5M | 2,011,952 | 5.4% |
| Stereotaxis Inc(STXS) | COM NEW | 85916J409 | $23.5M | 13,680,554 | 4.5% |
| Nektar Therapeutics(NKTR) | COM NEW | 640268306 | $22.2M | 318,380 | 4.2% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $19.0M | 739,014 | 3.6% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $18.5M | 497,240 | 3.5% |
| Atricure Inc(ATRC) | COM | 04963C209 | $16.7M | 597,431 | 3.2% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $15.1M | 250,772 | 2.9% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $14.7M | 171,998 | 2.8% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $13.6M | 441,829 | 2.6% |
| Ascendis Pharma A/S(ASND) | ORD SHS | K08588103 | $12.9M | 48,469 | 2.5% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $9.7M | 57,769 | 1.9% |
| Axogen Inc(AXGN) | COM | 05463X106 | $9.7M | 208,960 | 1.8% |
| Insulet Corp(PODD) | COM | 45784P101 | $9.4M | 61,870 | 1.8% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $9.2M | 226,819 | 1.8% |
| Bicara Therapeutics Inc(BCAX) | COM | 055477103 | $8.5M | 284,955 | 1.6% |
| Ishares Nasdaq Biotech Indx(IBB) | ETF | 464287556 | $8.1M | 42,595 | 1.5% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $7.3M | 335,255 | 1.4% |
| Maplight Therapeutics Inc(MPLT) | COM | 56565P103 | $6.1M | 171,006 | 1.2% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $6.1M | 2,008,164 | 1.2% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $5.9M | 2,400,458 | 1.1% |
| Dexcom Inc(DXCM) | COM | 252131107 | $5.8M | 86,279 | 1.1% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $5.8M | 149,524 | 1.1% |
| Inogen Inc(INGN) | COM | 45780L104 | $5.5M | 845,179 | 1.0% |
| Tandem Diabetes Care Inc(TNDM) | COM | 875372203 | $5.4M | 355,208 | 1.0% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $5.3M | 101,266 | 1.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $4.3M | 130,875 | 0.8% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $4.2M | 2,000,000 | 0.8% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $4.0M | 400,248 | 0.8% |
| Lakefront Biotherapeutics NV(GLPG) | SPON ADR | 36315X101 | $3.9M | 130,175 | 0.7% |
| Orthopediatrics Corp(KIDS) | COM | 68752L100 | $3.6M | 189,130 | 0.7% |
| Cybin Inc(HELP) | COM NEW | 23256X407 | $3.4M | 514,061 | 0.6% |
| Rapport Therapeutics Inc(RAPP) | COM | 75383L102 | $3.1M | 75,000 | 0.6% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $3.1M | 27,000 | 0.6% |
| Proqr Therapeutics NV | SHS EURO | N71542109 | $2.8M | 1,530,361 | 0.5% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $2.8M | 89,032 | 0.5% |
| Adlai Nortye LTD(ANL) | SPONSORED ADS | 00704R109 | $2.8M | 239,553 | 0.5% |
| Procept Biorobotics Corp(PRCT) | COM | 74276L105 | $2.7M | 120,000 | 0.5% |
| Aquestive Therapeutics Inc(AQST) | COM | 03843E104 | $2.7M | 645,915 | 0.5% |
| Celldex Therapeutics Inc(CLDX) | COM NEW | 15117B202 | $2.5M | 68,518 | 0.5% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $2.5M | 46,500 | 0.5% |
| Align Technology Inc(ALGN) | COM | 016255101 | $2.4M | 14,000 | 0.5% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $2.3M | 59,516 | 0.4% |
| Nervgen Pharma Corp(NGEN) | COM | 64082X203 | $2.2M | 1,050,000 | 0.4% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $2.0M | 137,593 | 0.4% |
| Maze Therapeutics Inc(MAZE) | COM | 578784100 | $1.9M | 65,000 | 0.4% |
| Alector Inc(ALEC) | COM | 014442107 | $1.8M | 908,351 | 0.3% |
| Lexeo Therapeutics Inc(LXEO) | COM | 52886X107 | $1.8M | 377,059 | 0.3% |
| Profound Medical Corp(PROF) | COM NEW | 74319B502 | $1.7M | 260,360 | 0.3% |